Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Claruvis, Curocell, Dr. Reddy’s, Emergent, Henlius, Hutchmed, Kyowa Kirin, Orchard, Telix.